Clay B. Siegall - Dec 13, 2023 Form 3 Insider Report for Tourmaline Bio, Inc. (TRML)

Role
Director
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
Stock symbol
TRML
Transactions as of
Dec 13, 2023
Transactions value $
$0
Form type
3
Date filed
12/15/2023, 04:21 PM
Previous filing
Oct 4, 2023
Next filing
Mar 8, 2024

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned